Risk factors for severe or fatal drug‐induced liver injury from amoxicillin–clavulanic acid

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|6|676-682

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.6, 2015-06, pp. : 676-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of amoxicillin‐ and clavulanic acid‐specific T cells in patients with amoxicillin‐clavulanate–induced liver injury

By  

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 887-899

John Wiley & Sons Inc

Access to resources Recommend Favorite

Managing the Risk of Drug‐Induced Liver Injury

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. : 629-631

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe drug‐induced liver injury related to therapy with dimethyl fumarate

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1367-1369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-01 ,pp. : 97-112

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers for drug-induced liver injury

By Watkins Paul B  

Therapy, Vol. 7, Iss. 4, 2010-07 ,pp. : 367-375

Future Medicine

Access to resources Recommend Favorite